This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tessier, C. R. Articles by Ross, J. Search for Related Content PubMed PubMed Citation Articles by Tessier, C. R. Articles by Ross, J.

Mammary Tumor Induction in Transgenic Mice Expressing an RNA-Binding Protein

¹McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, Wisconsin, and ²Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

We have analyzed mammary tumors arising in transgenic mice expressing a novel, multifunctional RNA-binding protein. The protein, which we call the c-myc mRNA coding region instability determinant binding protein (CRD-BP), binds to c-myc, insulin-like growth factor II, and ß-actin mRNAs, and to H19 RNA. Depending on the RNA substrate, the CRD-BP affects RNA localization, translation, or stability. CRD-BP levels are high during fetal development but low or undetectable in normal adult tissues. The CRD-BP is linked to tumorigenesis, because its expression is reactivated in some adult human breast, colon, and lung tumors. These data suggest the CRD-BP is a proto-oncogene. To test this idea, the CRD-BP was expressed from the whey acidic protein (WAP) promoter in mammary epithelial cells of adult transgenic mice. The incidence of mammary tumors was 95% and 60% in two lines of WAP-CRD-BP mice with high and low relative CRD-BP expression, respectively. Some of the tumors metastasized. Nontransgenic mice did not develop mammary tumors. H19 RNA and insulin-like growth factor II mRNA were up-regulated significantly in non-neoplastic WAP-CRD-BP mammary tissue. WAP-CRD-BP mice are a novel model for mammary neoplasia and might provide insights into human breast cancer biology.

This article has been cited by other articles:

				J. Christiansen, A. M Kolte, T. v O Hansen, and F. C Nielsen IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes J. Mol. Endocrinol., November 1, 2009; 43(5): 187 - 195. [Abstract] [Full Text] [PDF]

				W. Gu, F. Pan, and R. H. Singer Blocking {beta}-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells J. Cell Sci., June 1, 2009; 122(11): 1895 - 1905. [Abstract] [Full Text] [PDF]

				R. de Sousa Abreu, P. C. Sanchez-Diaz, C. Vogel, S. C. Burns, D. Ko, T. L. Burton, D. T. Vo, S. Chennasamudaram, S.-Y. Le, B. A. Shapiro, et al. Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes J. Biol. Chem., May 1, 2009; 284(18): 12125 - 12135. [Abstract] [Full Text] [PDF]

				W. Gu, A. L. Wells, F. Pan, and R. H. Singer Feedback Regulation between Zipcode Binding Protein 1 and {beta}-Catenin mRNAs in Breast Cancer Cells Mol. Cell. Biol., August 15, 2008; 28(16): 4963 - 4974. [Abstract] [Full Text] [PDF]

				K. Lapidus, J. Wyckoff, G. Mouneimne, M. Lorenz, L. Soon, J. S. Condeelis, and R. H. Singer ZBP1 enhances cell polarity and reduces chemotaxis J. Cell Sci., September 15, 2007; 120(18): 3173 - 3178. [Abstract] [Full Text] [PDF]

				D. Sparanese and C. H. Lee CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease Nucleic Acids Res., February 28, 2007; 35(4): 1209 - 1221. [Abstract] [Full Text] [PDF]

				K. Song, T. L. Krebs, and D. Danielpour Novel Permissive Role of Epidermal Growth Factor in Transforming Growth Factor beta (TGF-beta) Signaling and Growth Suppression: MEDIATION BY STABILIZATION OF TGF-beta RECEPTOR TYPE II J. Biol. Chem., March 24, 2006; 281(12): 7765 - 7774. [Abstract] [Full Text] [PDF]

				J. Spence, B. M. Duggan, C. Eckhardt, M. McClelland, and D. Mercola Messenger RNAs under Differential Translational Control in Ki-ras-Transformed Cells Mol. Cancer Res., January 1, 2006; 4(1): 47 - 60. [Abstract] [Full Text] [PDF]

				N. A Hammer, T. v O Hansen, A. G. Byskov, E. Rajpert-De Meyts, M. L. Grondahl, H. E Bredkjaer, U. M Wewer, J. Christiansen, and F. C Nielsen Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer Reproduction, August 1, 2005; 130(2): 203 - 212. [Abstract] [Full Text] [PDF]

				P. Ioannidis, L. G. Mahaira, S. A. Perez, A. D. Gritzapis, P. A. Sotiropoulou, G. J. Kavalakis, A. I. Antsaklis, C. N. Baxevanis, and M. Papamichail CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells J. Biol. Chem., May 20, 2005; 280(20): 20086 - 20093. [Abstract] [Full Text] [PDF]

				B. Liao, Y. Hu, D. J. Herrick, and G. Brewer The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia Cells J. Biol. Chem., May 6, 2005; 280(18): 18517 - 18524. [Abstract] [Full Text] [PDF]

				W. Wang, S. Goswami, K. Lapidus, A. L. Wells, J. B. Wyckoff, E. Sahai, R. H. Singer, J. E. Segall, and J. S. Condeelis Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors Cancer Res., December 1, 2004; 64(23): 8585 - 8594. [Abstract] [Full Text] [PDF]

				B. Liao, M. Patel, Y. Hu, S. Charles, D. J. Herrick, and G. Brewer Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells J. Biol. Chem., November 19, 2004; 279(47): 48716 - 48724. [Abstract] [Full Text] [PDF]

				J. Nielsen, M. A. Kristensen, M. Willemoes, F. C. Nielsen, and J. Christiansen Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability Nucleic Acids Res., August 16, 2004; 32(14): 4368 - 4376. [Abstract] [Full Text] [PDF]